|
 |
商品名 |
|
|
商品名、賦形剤は国、製薬会社ごとに異なることがあります
|
|
Becenun |
ブラジル |
|
Bicnu |
アイルランド, アメリカ, アーストラリア, イギリス, イラン, カナダ, ギリシア, コロンビア, スイス, スペイン, チュニジア, チリ, ニュージーランド, ハンガリー, フランス, ペルー, メキシコ, モロッコ, ルーマニア |
|
Bodacler |
アルゼンチン |
|
Carmubris |
イラン, オーストリア, ドイツ |
|
Carmustina Grey |
ペルー |
|
Carmustina Perulab |
ペルー |
|
Carmustine Baxter |
ニュージーランド |
|
Carmustine Obvius |
アイスランド, アイルランド, イギリス, オランダ, オーストリア, クロアチア, スウェーデン, スペイン, スロバキア, スロベニア, チェコ, デンマーク, ドイツ, ノルウェー, ハンガリー, フィンランド, フランス, ブルガリア, ベルギー, ポルトガル, ポーランド, ルクセンブルグ, ルーマニア |
|
Nitrourean |
スペイン |
|
Nitrumon |
イラン, ベルギー, ルクセンブルグ |
|
|
 |
 |
引用文献 : Carmustine |
|
|
形式 |
出版物 |
| 3 |
雑誌 |
Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212. |
| 81 |
雑誌 |
Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678. |
| 84 |
雑誌 |
Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499. |
| 99 |
雑誌 |
Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090. |
| 146 |
雑誌 |
Hadji-Minaglou-Gonzalvez MF, Gayte-Sorbier A, Airauto CB, Verdier M.
Effects of temperature, solution composition, and type of container on the stability and absorption of carmustine.
Clin Ther 1992 ; 14: 821-824. |
| 169 |
雑誌 |
Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363. |
| 182 |
雑誌 |
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60. |
| 244 |
雑誌 |
Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913. |
| 249 |
雑誌 |
Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045. |
| 307 |
雑誌 |
Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799. |
| 334 |
雑誌 |
Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992. |
| 335 |
雑誌 |
Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406. |
| 492 |
雑誌 |
Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189. |
| 715 |
雑誌 |
Colvin M, Hartner J, Summerfield M.
Stability of carmustine in the presence of sodium bicarbonate.
Am J Hosp Pharm 1980 ; 37: 677-678. |
| 837 |
雑誌 |
Fredriksson K, Lundgren P, Landersjo L.
Stability of carmustine - kinetics and compatibility during administration.
Acta Pharm Suec 1986 ; 23: 115-124. |
| 905 |
雑誌 |
Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017. |
| 1410 |
雑誌 |
Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145. |
| 1423 |
雑誌 |
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518. |
| 1501 |
雑誌 |
Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M.
Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials.
Int J Pharm 1999 ; 185: 113-121. |
| 1520 |
実験 |
Etude de stabilité des médicaments en Ecoflac®
B Braun 2001 |
| 1622 |
雑誌 |
Favier M, De Casanove F, Coste A, Cherti N, Bressolle F.
Stability of carmustine in polyvinyl chloride bags and polyethylene-lined trilayer plastic containers.
Am J Health-Syst Pharm 2001 ; 58: 238-241. |
| 2146 |
雑誌 |
Trissel LA, Xu QA, Baker M.
Drug compatibility with new polyolefin infusion solution containers.
Am J Health-Syst Pharm 2006 ; 63: 2379-2382. |
| 3314 |
実験 |
Carmustine (Bicnu®) – Résumé des caractéristiques du produits
Bristol Myers Squibb 2011 |
| 4762 |
雑誌 |
Knoll L, Kraemer I, Thiesen J.
Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature
EJHP 2023 ; 30, 1: 11-16. |
|
|
